Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival
Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla
Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla
View: Text | PDF
Research Article Cell biology Microbiology

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival

  • Text
  • PDF
Abstract

The drive to withstand environmental stresses and defend against invasion is a universal trait extant in all forms of life. While numerous canonical signaling cascades have been characterized in detail, it remains unclear how these pathways interface to generate coordinated responses to diverse stimuli. To dissect these connections, we followed heparanase (HPSE), a protein best known for its endoglycosidic activity at the extracellular matrix but recently recognized to drive various forms of late-stage disease through unknown mechanisms. Using herpes simplex virus-1 (HSV-1) infection as a model cellular perturbation, we demonstrate that HPSE acts beyond its established enzymatic role to restrict multiple forms of cell-intrinsic defense and facilitate host cell reprogramming by the invading pathogen. We reveal that cells devoid of HPSE are innately resistant to infection and counteract viral takeover through multiple amplified defense mechanisms. With a unique grasp of the fundamental processes of transcriptional regulation and cell death, HPSE represents a potent cellular intersection with broad therapeutic potential.

Authors

Alex Agelidis, Benjamin A. Turturice, Rahul K. Suryawanshi, Tejabhiram Yadavalli, Dinesh Jaishankar, Joshua Ames, James Hopkins, Lulia Koujah, Chandrashekhar D. Patil, Satvik R. Hadigal, Evan J. Kyzar, Anaamika Campeau, Jacob M. Wozniak, David J. Gonzalez, Israel Vlodavsky, Jin-ping Li, David L. Perkins, Patricia W. Finn, Deepak Shukla

×

Figure 3

HPSE restricts type I IFN response and drives virus production through inhibition of degradation of immediate early protein ICP0.

Options: View larger image (or click on image) Download as PowerPoint
HPSE restricts type I IFN response and drives virus production through i...
(A) Transcriptomic and proteomic datasets filtered based on Hallmark_Interferon_Alpha_Response gene set (n = 91 genes) obtained from mSigDb. (B) Transcript expression of Hallmark_Interferon_Alpha_Response subset displayed as fold change over baseline, with bolded lines signifying mean expression and shaded areas indicating SEM. Splines generated using MetaLonDA. (C) Increased type I IFN sensitivity in Hpse-/- cells at baseline and with IFN-β administration for 18 hours, exemplified by expression of IFN-stimulated gene (ISG15) monomer and protein-conjugated forms. (D) Representative Western blot analysis of cell lysates from WT and Hpse-/- MEFs indicating selective defect in viral protein production in HPSE deficiency. gB is a late (γ) gene, while ICP4, ICP27, and ICP0 are immediate early (α) genes. (E) Western blot analysis of cell lysate, isotype immunopurification, and ICP0 immunopurification of WT and Hpse-/- cells after 24-hour HSV-1 infection, with 10 μM MG132 added for the final 4 hours. (F) Immediate early viral protein expression in the presence of proteasome inhibitor MG132 (10 μM for last 4 hours of 24-hour infection) shown by Western blot analysis of cell lysates. (G) Proposed model depicting ability of HPSE to interfere with ISG15 conjugation and proteasomal degradation of viral ICP0.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts